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Abstract
Introduction: We sought to determine the effect of nutritional support and insulin infusion therapy on serum and
brain glucose levels and cerebral metabolic crisis after aneurysmal subarachnoid hemorrhage (SAH).
Methods: We used a retrospective observational cohort study of 50 mechanically ventilated poor-grade (Hunt-Hess
4 or 5) aneurysmal SAH patients who underwent brain microdialysis monitoring for an average of 109 hours.
Enteral nutrition was started within 72 hours of admission whenever feasible. Intensive insulin therapy was used to
maintain serum glucose levels between 5.5 and 7.8 mmol/l. Serum glucose, insulin and caloric intake from enteral
tube feeds, dextrose and propofol were recorded hourly. Cerebral metabolic distress was defined as a lactate to
pyruvate ratio (LPR) > 40. Time-series data were analyzed using a general linear model extended by generalized
estimation equations (GEE).
Results: Daily mean caloric intake received was 13.8 ± 6.9 cal/kg and mean serum glucose was 7.9 ± 1 mmol/l.
A total of 32% of hourly recordings indicated a state of metabolic distress and < 1% indicated a state of critical brain
hypoglycemia (< 0.2 mmol/l). Calories received from enteral tube feeds were associated with higher serum glucose
concentrations (Wald = 6.07, P = 0.048), more insulin administered (Wald = 108, P < 0.001), higher body mass index
(Wald = 213.47, P < 0.001), and lower body temperature (Wald = 4.1, P = 0.043). Enteral feeding (Wald = 1.743, P =
0.418) was not related to brain glucose concentrations after accounting for serum glucose concentrations (Wald =
67.41, P < 0.001). In the presence of metabolic distress, increased insulin administration was associated with a relative
reduction of interstitial brain glucose concentrations (Wald = 8.26, P = 0.017), independent of serum glucose levels.
Conclusions: In the presence of metabolic distress, insulin administration is associated with reductions in brain
glucose concentration that are independent of serum glucose levels. Further study is needed to understand how
nutritional support and insulin administration can be optimized to minimize secondary injury after subarachnoid
hemorrhage.
Introduction
Hyperglycemia, defined as serum glucose > 11 mmol/l
after subarachnoid hemorrhage, is a common finding and
is an independent predictor of long term poor outcome
[1,2]. It is believed that the surge in serum glucose imme-
diately after injury is related to a complex interrelation-
ship between sympathetic and inflammatory mediators,
acquired insulin resistance and administration of dexa-
methasone [3].
While such observational data argue for tight glycemic
control, recent studies investigating the relationship
between serum and brain glucose levels have found that
intensive insulin protocols targeted to a tight serum glu-
cose level (4.4 to 6.1 mmol/l) may compromise cerebral
metabolism by leading to concomitant critical reductions
in interstitial brain glucose levels [4,5].
Each of these studies did not take into account the
impact that nutritional support may have upon outcomes
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related to tight glycemic control. The adequate delivery of
non-protein calories was rigorously maintained in rando-
mized controlled trials of surgical and medical ICU
patients [6-8], and a recent single center study of SAH
patients found that a bolus delivery of enteral nutrition
significantly impacted brain glucose levels [9].
We sought to understand the impact enteral nutrition
has upon the relationship between serum and brain inter-
stitial glucose levels in a cohort of subarachnoid hemor-
rhage patients treated with institutional protocol
targeting serum glucose levels between 5.5 to 7.8 mmol/l.
We hypothesized that higher non-protein caloric delivery
would result in higher interstitial brain glucose levels and
reduce the incidence of brain metabolic crisis.
Materials and methods
Patient selection and data collection
Between June 2006 and August 2010 data were collected
from 50 consecutive aneurysmal subarachnoid hemor-
rhage (SAH) patients admitted to the neurological ICU at
Columbia University Medical Center, who underwent
cerebral metabolism monitoring as part of their clinical
care. All patients were enrolled in the Columbia University
SAH Outcomes Project. This observational study was
approved by the Columbia University Medical Center Insti-
tutional Review Board, and in all cases written informed
consent was obtained from the patient or a surrogate.
Details regarding data collection have been described pre-
viously [10]. The diagnosis of SAH was established on the
basis of an admission CT scan or by presence of xantho-
chromia in the cerebrospinal fluid. Patients with secondary
SAH related to trauma, rupture of an cerebral arteriove-
nous malformation (AVM), or other causes; age < 18 years;
or admission > 14 days after SAH onset were excluded
from the study.
Clinical and radiographic variables
The calendar day of the index bleeding event was desig-
nated SAH Day 0. We recorded baseline demographic
data, location and size of the aneurysm, angiographic and
transcranial Doppler ultrasonography (TCD) findings,
and mode of aneurysm treatment (clipping versus coil-
ing). Neurological status on admission was assessed with
the Hunt-Hess scale [11], and the Glasgow Coma Scale
(GCS; [12]). We also assessed the Acute Physiology and
Chronic Health Evaluation II (APACHE II) scale [13] and
calculated a physiological sub-score by subtracting the
GCS score, age and chronic health elements from the
total score [14]. Admission and follow-up CT scans were
independently evaluated by a study neurointensivist for
the amount and location of subarachnoid blood (SAH
sum score, scaled 0 = no blood, 30 = all cisterns and fis-
sures completely filled) [15], intraventricular blood (IVH
sum score, scaled 0 = no blood, 12 = all ventricles
completely filled) [16], the presence and degree of hydro-
cephalus [17], the presence of cerebral edema [18], and
cerebral infarction.
Clinical management
Clinical management conformed to guidelines set forth
by the American Heart Association [19]. External ventri-
cular drainage (EVD) was placed in all patients with
symptomatic hydrocephalus or intraventricular hemor-
rhage with a reduced level of consciousness. All patients
were followed with daily or every-other-day TCD,
received oral nimodipine and intravenous hydration with
0.9% saline and 250 ml of 5% albumin solution to main-
tain a central venous pressure > 5 cm H2O. Clinical dete-
rioration from delayed cerebral ischemia (DCI) was
treated with hypertensive hypervolemic therapy (HHT)
to maintain systolic blood pressure (SBP) between 160
and 220 mm Hg, as required to reverse the neurological
deficit. Comatose patients were mechanically ventilated
and treated with propofol, fentanyl or dexmedetomidine
to facilitate ventilator synchrony, with interruptions in
sedation for clinical assessments at least twice daily.
Computed tomography (CT) was performed serially
when clinically needed. All patients with clinical dete-
rioration underwent CT or magnetic resonance imaging
(MRI) scanning to identify causes of deterioration other
than vasospasm whenever clinically feasible. When clini-
cal evidence of DCI persisted for more than two hours
despite HHT, cerebral angiography was used to identify
vasospasm and balloon angioplasty or intra-arterial
administration of verapamil was performed whenever
feasible.
Nutritional management
Nutrition support was begun within 24 hours after aneur-
ysmal repair. Enteral nutrition was the preferred route and
was provided via a naso-duodenal tube starting within the
first 24 hours of admission. All nutritional formulas were
started at 50% of goal and were titrated by 25% every four
hours until targeted caloric intake was achieved. Feeds
were held for two hours if 100 cc of residual feeds were
noted in the FARRELL® valve bag (Corpak MedSystems,
Inc., Buffalo Grove, IL, USA), and resumed once the FAR-
RELL® emptied. The target goal was 25 calories/kg/day of
ideal body weight. No parenteral nutrition was given [20].
The type of enteral formula used was determined by the
clinical nutritionist. All nutrition data were adjusted for
actual body weight.
Serum glucose management
Serum glucose was measured with the Sure Step Flexx sys-
tem (Lifescan, Milpitas, CA, USA) and the target range
was between 5.5 and 7.8 mmol/l (100 to 140 mg/dL) as
part of an institutionally approved tight serum glucose
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control protocol using intravenous insulin infusion
(Humulin, Novo Nordisk, Princeton, NJ, USA) [7].
Cerebral metabolism
A CMA 70 microdialysis catheter with 10 mm membrane
length (CMA Microdialysis®, Stockholm, Sweden) was
inserted at the bedside through the same triple-lumen
bolt as intracranial pressure (ICP) and brain tissue oxy-
gen tension (PbtO2). Immediately after the procedure, a
brain CT scan was performed in each patient to confirm
the proper location of the microdialysis catheter in the
normal appearing white matter. The CMA 106 microdia-
lysis perfusion pump (CMA Microdialysis®) was used to
perfuse the interior of the catheter with sterile artificial
cerebrospinal fluid (Na+ 148 mmol/L, Ca2+ 1.2 mmol/L,
Mg2+ 0.9 mmol/L, K+ 2.7 mmol/L, Cl- 155 mmol/L) at a
rate of 0.3 μl/minute. Samples were collected in micro-
vials approximately every 60 minutes and immediately
analyzed at the bedside for glucose, lactate and pyruvate
with the CMA 600 analyzer (CMA Microdialysis®). At
least one hour passed after the insertion of the probe and
the start of the sampling to allow for normalization of
changes due to probe insertion. The analyzer was auto-
matically calibrated on initiation and every six hours
using standard calibration solutions from the manufac-
turer. Quality controls at three different concentrations
for each marker were performed daily.
Statistical analysis
Caloric intake was quantified for enteral nutrition, dex-
trose infusions and propofol infusions. The volume (mL)
of enteral nutrition delivered each hour was recorded and
multiplied by the appropriate factor provided for each spe-
cific formulation. Hourly volumes (mL) of dextrose were
converted into grams of dextrose and multiplied by 3.4 cal-
ories/gram dextrose. Propofol volumes (mL) were con-
verted to calories by a factor of 1.1 calories/mL. Metabolic
crisis was defined as a lactate/pyruvate ratio greater than
40 [5]. Comparisons of pooled data were carried out using
a generalized linear model (GLM) using a normal distribu-
tion and identity link function and were extended by gen-
eralized estimating equations (GEE) using the
autoregressive process (AR-1) [21] to handle repeated
observations within subject. Data were transformed to
meet assumptions of normality or converted into ordinal
factors based on median or quartile values. Brain glucose
was transformed using a square root transformation
(bGlu_sqrt) whereas a Log transformation was applied to
the lactate/pyruvate ratio (LPR_log). A Cook’s distance
was calculated in a linear analysis of bGlu_sqrt and
LPR_log to identify outliers and a filter was applied using
a cutoff of greater than 4/N [22] to remove the remaining
data points that would distort linear analysis. SPSS 18 soft-
ware® (IBM SPSS Inc., Chicago, IL, USA) was used for
data analysis. A P-value < 0.05 was considered statistically
significant.
Results
Baseline characteristics and nutrition
Fifty aneurysmal SAH patients met study criteria and were
monitored for a total of 5,445 hours (108 +/- 73 hours/
patient) between June 2006 and August 2010. The median
Hunt &Hess Score on admission was 4 (IQR: 3, 5) and
mean APACHE II score was 22 +/- 8 (Table 1). Neuromo-
nitoring began within four days after SAH in all but four
patients (median = 2 days, IQR = 1 to 3.5 days). Enteral
nutrition started on SAH bleed Day 4 +/- 2. The daily
mean non-protein caloric intake was 14.8 ± 10.7 cal/kg
and daily nitrogen intake was 0.087 ± 0.085 g/kg. The
daily mean caloric intake from enteral tube feeds during
the study period was 10.63 +/- 6.9 calories/kg/day, from
dextrose 0.85 +/- 1.4 calories/kg/day, and from propofol
Table 1 Baseline characteristics of subarachnoid
hemorrhage patients (N = 50)
Characteristic Value1
Age, years 51.2 (14.7)
Women 32 (64%)
Ethnicity
White, non-Hispanic 18 (36%)




Diabetes mellitus 5 (10%)
Hypertension 17 (34%)
Liver Disease 2 (4%)
Kidney Disease 0 (0%)
Body Mass Index, kg/m2 26 (5)
APACHE II score2 22 (8)
Glasgow Coma Scale 6 (5)
Aneurysm size, mm3 7.7 (3.8)
Aneurysm clipping 26 (52%)











1 All continuous measures are shown as mean (SD), ordinal measures as
median (IQR), and nominal measures as N(%). 2 Acute Physiological and
Chronic Health Evaluation Score. 3 One patient had a dysplastic aneurysm that
was not measured for diameter.
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2.27 +/- 2.26 calories/kg/day totaling overall 13.77 +/- 6.95
calories/kg/day (Table 2). Patients had a mean serum glu-
cose of 7.9 +/- 1 mmol/l, brain glucose of 1.21 +/-
0.60 mmol/l, and LPR of 37 +/- 14. Higher insulin admin-
istration (IU) was associated with higher caloric intake
from enteral tube feeds (Wald = 9.49, P = 0.009).
Serum glucose
On univariate analysis, higher serum glucose levels were
associated with higher brain glucose concentrations
(Wald = 30.4, P < 0.001), doses of insulin administration
(IU/hr: Wald = 92.25, P < 0.001), body mass index
(Wald = 213.47, P < 0.001), and lower body temperature
(Wald = 4.1, P = 0.043). Combined calories received
from carbohydrates and dextrose administration were
significantly related to serum glucose concentrations
(Wald = 27.631, P < 0.001, Figure 1) but associations
were not found for total calories from enteral feeding
(Wald = 2.173, P = 0.337), dextrose administration
(Wald = 1.434, P = 0.488), or propofol (Wald = 5.284,
P = 0.071). Multifactorial analysis revealed that
increased calories from enteral feeding (Wald = 6.07,
P = 0.048), higher insulin doses (Wald = 108.2, P <
0.001), and presence of brain metabolic crisis (LPR >
40) (Wald = 4.4, P = 0.036) were significantly associated
with higher serum glucose concentrations. Insulin
administration modified the relationship between serum
glucose and enteral calories (Wald = 9.96, P = 0.041)
such that serum glucose concentrations increases were
smaller in magnitude in the presence of insulin adminis-
tration, but insulin did not impact the relationship
between serum glucose and brain metabolic crisis (Wald =
3.48, P = 0.176) (Table 3, Figure 2).
Brain glucose
Univariate analysis revealed that higher brain glucose was
related to higher insulin doses (Wald = 24.68, P < 0.001)
and body mass index (Wald = 97.98, P < 0.001), while
lower brain glucose levels were associated with metabolic
crisis (LPR > 40; Wald = 14.79, P < 0.001). There was no
association observed between brain glucose levels and
calories received from enteral feeding (Wald = 0.947, P =
0.623), propofol (Wald = 3.153, P = 0.207), dextrose
(Wald = 5.76, P = 0.056) or body temperature (Wald =
3.05, P = 0.08). Multifactorial analysis revealed that ent-
eral feeding (Wald = 1.743, P = 0.418) was not related to
brain glucose concentrations after accounting for the
positive relationship of serum glucose concentrations
(Wald = 67.41, P < 0.001) and negative relationship of
metabolic crisis (Wald = 4.61, P = 0.032) to brain glucose
concentrations. In this model insulin administration
(Wald = 3.15, P = 0.208) was not associated with brain
glucose but was modified by the existence of metabolic
crisis (Wald = 8.26, P = 0.016) such that in the presence
of metabolic crisis, administration of greater than two
units of insulin was associated with a relative reduction
of brain glucose concentrations (Table 4, Figure 2).
Discussion
In this study of 50 poor-grade SAH patients, we found
that our insulin protocol maintained serum glucose levels
≤ 7.8 mmol/l and similar to previous observations that
low serum glucose levels were associated with brain
metabolic crisis. We were unable; however, to directly
demonstrate our central hypothesis that higher non- pro-
tein caloric delivery results in higher interstitial brain glu-
cose levels. In contrast, Kinoshita et al. [9] demonstrated
increases in serum and brain glucose concentrations two
hours after a 250-calorie bolus of ENSURE® (Abbott
Laboratories, Inc., Columbus, Ohio, USA {). This discre-
pancy is likely due to a significantly lower caloric delivery
in our patients (0.442 calories/kg/hour) in combination
with our intravenous insulin protocol that is designed to
maintain serum glucose levels within a range of 5.5 to
7.8 mmol/l. Kinosheta et al. provided bolus feeds that
resulted in higher serum glucose levels (183.8 ± 26.2 mg/
dL) that were actively controlled in our observational
study. This is a limitation experimentally but does sug-
gest that brain metabolism is not supported by enteral
nutrition under normal clinical circumstances. Under-
feeding is a common problem in critically ill patients and
as we and others have shown, it is associated with higher
rates of medical and infectious complications as well as
poor long term outcome [23,24].
As expected, we observed greater administration of insu-
lin as serum glucose levels increased. However, we were
surprised to observe a different relationship between brain
glucose levels and insulin doses. In 2011, Zetterling et al.
[25] reported that insulin administration lowered cerebral
microdialysis brain glucose and pyruvate concentrations,
often to low levels, despite plasma glucose remaining
above 6 mmol/L. While cerebral metabolism monitoring
is used to detect acute events, in practice severity of the
initial brain injury is the primary determinate of observed
metabolic status [26]. An LPR greater than 40 has been
established in the literature to represent a state of brain
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perhaps the effect of insulin on brain glucose concentra-
tion is altered by the severity of injury of the tissue being
monitored. We found that when metabolic status was not
critical (LPR < 40) that the brain glucose-insulin adminis-
tration relationship was similar to the serum glucose-
insulin administration relationship. In contrast, during
metabolic crisis (LPR ≥ 40) a negative relationship was
observed, such that higher insulin doses (> 2 IU/hr) were
associated with a lower brain glucose level. While our
observational study design restricts our ability to infer
Figure 1 Calories and Systemic Glucose. Range plot of positive relationship between serum glucose to caloric intake from carbohydrates and
dextrose (Wald = 27.631, P < 0.001). Serum glucose estimated marginal mean and 95% confidence interval is presented.
Table 3 Serum glucose: multifactorial associations
Characteristic Estimate (95% Confidence Interval) P-Value
Enteral feeds (cal/kg/hour)
0 to 0.068 (Reference)
0.069 to 0.697 0.115 (-0.065, 0.296) 0.21
0.70 to 2.16 0.249(-0.021, 0.520) 0.07
Insulin administration (units)
0 (Reference)
1 to 2 0.678 (0.412, 0.944) < 0.001
> 2 1.526 (1.124, 1.927) < 0.001
Lactate/pyruvate ratio ≤ 40 -0.472 (-0.912, -0.032) 0.036
Enteral feeds * Insulin administration
0 to 0.068 Cal/kg/hour * 0 units (Reference)
0.069 to 0.697 Cal/kg/hour * 1 to 2 units -0.356 (-0.676, -0.036) 0.029
0.069 to 0.697 Cal/kg/hour * > 2 units -0.562 (-0.980, -0.144) 0.008
0.70 to 2.16 Cal/kg/hour * 1 to 2 units -0.232 (-0.646, 0.182) 0.272
0.70 to 2.16 Cal/kg/hour * > 2 units -0.216 (-0.787, 0.355) 0.458
Insulin Administration * LPR ≤ 40
Insulin Administration > 2 units * LPR ≤ 40 (Reference)
Insulin Administration 1 to 2 units * LPR ≤ 40 0.160 (-0.035, 0.594) 0.436
Insulin Administration 0 units * LPR ≤ 40 0.419 (-0.067, 0.904) 0.091
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causal relationships between insulin and brain glucose, our
observations do appear congruent with the findings of
Zetterling et al.
It is physiologically plausible that the effect of insulin
on brain glucose metabolism may be altered by brain
injury. Previous experimental and clinical studies have
shown that insulin increases glucose transport across the
blood-brain barrier [28], promotes glucose storage as
glycogen in astrocytes [29], and stimulates protein and
RNA and DNA synthase in the brain [30,31]. High con-
centrations of endogenous insulin may enable brain cells
to divert glucose metabolism to secondary pathways
[32,33] that may be important to neuronal repair, includ-
ing fatty acid and amino acid production, and the pentose
phosphate shunt pathway, which may be important to
protect against oxidative damage [34].
Figure 2 Calories and Brain Glucose. Observed association between insulin and brain glucose is modified by presence of metabolic crisis at
the probe location. Brain glucose estimated marginal mean and 95% confidence interval is presented.
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It is conceivable that protocol-driven clinical adminis-
tration of insulin to maintain serum glucose concentra-
tions may provide a dangerous false signal to injured
brain tissue that excess glucose is available and can be
diverted from ATP production to secondary pathways for
tissue repair functions. Vespa et al., [4] conducted a dual
microdialysis positron emission tomography (PET) scan
study in traumatic brain injury patients demonstrating
that even though intensive insulin therapy resulted in
lower brain glucose concentrations, the global metabolic
rate of glucose did not change and that this corresponded
with signs of energy failure, including oxygen extraction
increases to near-ischemia level and brain glutamate and
lactate pyruvate ratio increases. Two other studies found
significant insulin-related reductions in brain glucose
concentrations but did not find evidence that this
resulted in increased metabolic distress [25,35]. However,
in both studies the reported mean LPR was approxi-
mately 30. No study has looked at the relationship
between brain glucose levels and insulin during cerebral
metabolic distress (LPR > 40). Glucose metabolism of
healthy brain tissue is stable and relatively unaffected by
normal alterations of cerebral perfusion in contrast to
that of injured brain tissue, which is very sensitive to
such changes [36].
It is currently unknown if providing additional nutri-
tional support to brain injured patients in combination
with insulin therapy may be important to support
increased cerebral energy demands and brain tissue recov-
ery. The current cohort of patients, on average, received
approximately half the amount of calories recommended
by the American College of Chest Physicians’ guidelines
for critically ill patients (approximately 25 calories/kg/day)
[20], but is consistent with reports of underfeeding of neu-
rological critically ill patients elsewhere [37]. We speculate
that the effect of insulin on brain glucose metabolism in
the context of brain injury remains poorly understood and
is in need of further study.
Our study has several limitations. The true impact of
enteral nutrition on brain metabolism is difficult to deter-
mine due to the fact that serum glucose concentrations
were actively controlled with insulin. Evaluating relatively
small-to-moderate differences in calories received over
time may also mask the effects of enteral nutrition on
brain metabolism. Individual responses to increases in cal-
ories received via enteral nutrition and the impact of insu-
lin infusions were not analyzed in this study. Although our
findings are consistent with the few studies available in
this area [4,9,25,35,38], a patient-specific analysis might
lead to different conclusions. This study does not provide
any data to clarify a mechanism for insulin-related reduc-
tions of brain glucose concentrations or suggest whether
adequate caloric intake (for example, 25 calories/kg/day)
might mitigate this effect. Prospective studies with con-
trolled amounts of caloric delivery are required to ade-
quately address these limitations.
Conclusions
Our data suggest that receiving even modest, though
typical [37], levels of nutritional support is an effective
way to increase serum glucose concentrations in poor-
grade SAH patients and, accordingly, results in increased
insulin administration to maintain target serum glucose
concentrations. Improved algorithms designed to avoid
underfeeding will be necessary to fully understand the
incidence, mechanism and impact of insulin-induced
reductions in brain glucose concentrations.
Key messages
• Higher caloric intake from enteral nutrition was
associated with higher serum glucose concentrations
and the amount of insulin administered.
Table 4 Brain glucose: multifactorial associations
Characteristic Estimate (95% confidence interval) P-Value
Enteral feeds (cal/kg/hour)
0 to 0.068 (Reference)
0.069 to 0.697 0.012 (-0.007, 0.032) 0.680
0.70 to 2.16 -0.006 (-0.036, 0.024) 0.213
Insulin administration (units)
0 (Reference)
1 to 2 0.018 (-0.014, 0.049) 0.275
> 2 0.039 (0.003, 0.076) 0.036
Serum glucose (mmol/L) 0.036 (0.027, 0.045) 0.000
Lactate/pyruvate ratio ≤ 40 0.089 (0.027, 0.152) 0.032
Insulin administration (units) * LPR ≤ 40
Insulin administration > 2 units * LPR ≤ 40 (Reference)
Insulin administration 1 to 2 units * LPR ≤ 40 -0.048 (-0.091, -0.005) 0.005
Insulin administration 0 units* LPR ≤ 40 -0.059 (-0.122, 0.004) 0.062
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• Caloric intake from enteral nutrition was not related
to brain glucose concentrations after accounting for
serum glucose concentrations.
• In the presence of metabolic distress, higher doses
of insulin were associated with lower brain glucose
levels.
• Further study is needed to understand how nutri-
tional support and insulin administration can be
optimized to minimize secondary injury after subar-
achnoid hemorrhage.
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